IDEX
357 hedge funds and large institutions have $9.08B invested in IDEX in 2017 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 111 increasing their positions, 136 reducing their positions, and 19 closing their positions.
235% more call options, than puts
Call options by funds: $5.47M | Put options by funds: $1.64M
158% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 19
8% more funds holding
Funds holding: 330 → 357 (+27)
6% more capital invested
Capital invested by funds: $8.57B → $9.08B (+$508M)
1.71% less ownership
Funds ownership: 99.51% → 97.8% (-1.7%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
18% less repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 136
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$73.9M |
| 2 |
Millennium Management
New York
|
+$17.1M |
| 3 |
Morgan Stanley
New York
|
+$17.1M |
| 4 |
O
OppenheimerFunds
New York
|
+$16.2M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$14.2M |
Top Sellers
IEX Hedge Fund Activity: Q3 2017 in Review
357 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in IDEX (IEX) for Q3 2017, worth a combined $9.08B — up 5.9% from $8.57B a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new IEX positions and 19 closed out — a net gain of 30 holders — while 111 added to existing stakes and 136 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $73.9M. The largest seller was T. Rowe Price Associates, cutting an estimated $46.8M.
- 357 institutional investors held IDEX (IEX) as of Q3 2017, up from 330 in Q2 2017.
- Funds reported $9.08B of IDEX stock for Q3 2017, up 5.9% quarter-over-quarter.
- 49 funds opened new IDEX positions in Q3 2017 and 19 closed out, a net change of +30 holders.
- The largest IDEX buyer in Q3 2017 was Wellington Management Group, an estimated $73.9M added.
- The largest IDEX seller in Q3 2017 was T. Rowe Price Associates, an estimated $46.8M sold.
Based on aggregated 13F filings for Q3 2017.